Gregory Ruhlmann

Title: Gregory Ruhlmann: A Pioneer in Drug Coating Innovations

Introduction:

Gregory Ruhlmann, based in Cupertino, California, is a trailblazing inventor known for his contributions to the world of drug coatings. With a portfolio of 2 patents to his name, Ruhlmann's inventive spirit and commitment to excellence have solidified his status as a leading figure in the field of pharmaceutical innovations.

Latest Patents:

Ruhlmann's latest patents showcase his expertise in developing drug coatings that boast high drug loading capabilities. The first patent revolves around aqueous drug coatings containing insoluble drugs, with the insoluble drug component constituting a significant percentage of the overall coating. The second patent delves into methods for creating drug coatings with optimal drug concentrations, incorporating both soluble and insoluble drugs for enhanced efficacy.

Career Highlights:

Currently affiliated with Alza Corporation, Ruhlmann has made significant strides in advancing drug coating technologies within the pharmaceutical industry. His innovative approach to drug formulation has garnered acclaim and positioned him as a driving force behind novel pharmaceutical solutions.

Collaborations:

In his professional journey, Ruhlmann has had the privilege of collaborating with top-tier professionals in the field. Noteworthy colleagues include Evangeline Cruz and Brenda J Pollock, whose collective expertise has further enriched Ruhlmann's innovative endeavors at Alza Corporation.

Conclusion:

Gregory Ruhlmann's unwavering dedication to pioneering drug coating innovations underscores his profound impact on the realm of pharmaceutical inventions. His collaborative spirit, coupled with a relentless pursuit of excellence, continues to inspire and shape the future landscape of drug development. As a visionary inventor, Ruhlmann's legacy serves as a beacon for aspiring inventors and innovators worldwide.